MGRX
Mangoceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MGRX fundamentals
Mangoceuticals (MGRX) released its earnings on Nov 14, 2025: revenue was 84.25K (YoY -36.83%), beat estimates; EPS was -0.69 (YoY +30.30%), missed estimates.
Revenue / YoY
84.25K
-36.83%
EPS / YoY
-0.69
+30.30%
Report date
Nov 14, 2025
EPS
Revenue
Revenue & Expenses
MGRX has released its 2025 Q3 earnings report, with revenue of 84.25K, reflecting a YoY change of -36.83%, and net profit of -7.62M, showing a YoY change of -281.00%. The Sankey diagram below clearly presents MGRX's revenue sources and cost distribution.
Key Indicators
Mangoceuticals (MGRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Mangoceuticals (MGRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Mangoceuticals (MGRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Mangoceuticals (MGRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Mangoceuticals (MGRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Mangoceuticals (MGRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Mangoceuticals's gross profit margin?What is the market's earnings forecast for Mangoceuticals next quarter?What is the revenue and EPS growth rate for Mangoceuticals year over year?What guidance did Mangoceuticals's management provide for the next earnings period?What is Mangoceuticals's latest dividend and current dividend yield?What were the key takeaways from Mangoceuticals’s earnings call?What does Mangoceuticals do and what are its main business segments?What were the key takeaways from Mangoceuticals's earnings call?
